feed,title,long_url,short_url
FDA:MedWatch,Prolia (denosumab): Drug Safety Communication -Â FDA Adds Boxed Warning for Increased Risk of Severe Hypocalcemia in Patients with Advanced Chronic Kidney Disease,http://www.fda.gov/safety/medical-product-safety-information/prolia-denosumab-drug-safety-communication-fda-adds-boxed-warning-increased-risk-severe-hypocalcemia,https://da.gd/8gIN
